• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Aspirin use was not effective at reducing mortality in patients hospitalized with COVID-19

byNeel MistryandTeddy Guo
January 25, 2022
in Cardiology, Hematology, Infectious Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. There was no significant difference in all-cause mortality and need for invasive mechanical ventilation among patients assigned to aspirin versus usual care group.

2. Although aspirin was associated with a reduction in rate of thrombotic events, there were also increases in major bleeding.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Patients hospitalized with COVID-19 often encounter thromboembolic events during their stay. Although current guidelines suggest use of low molecular weight heparin (LMWH), more affordable and accessible drugs should be explored. Aspirin, a cyclooxygenase-1 enzyme (COX-1) inhibitor, is known to reduce both arterial and venous thrombotic events although its use in patients with COVID-19 lacks evidence. This randomized control trial aimed to assess the safety and efficacy of aspirin among patients admitted with COVID-19. Individuals were assigned to either standard of care plus aspirin (intervention group) or standard of care alone (control group). The primary outcome was mortality at 28 days, while key secondary outcomes included length of hospital stay and need for mechanical ventilation. According to study results, all-cause mortality was similar in both groups, although individuals in the intervention group experienced a shorter hospital stay. A notable limitation of this study was that patients already using aspirin, likely due to increased cardiovascular risk factors, were excluded from study enrollment. Nonetheless, this randomized controlled trial provides crucial information regarding the efficacy of aspirin for a large sample of patients with COVID-19.

Click to read the study in The Lancet

Relevant Reading: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

In-depth [randomized controlled trial]: Between Nov 1, 2020, and Mar 21, 2021, 22 560 patients were assessed for eligibility across 177 hospitals in the UK, Indonesia, and Nepal. Included were those ≥18 years with suspected or confirmed COVID-19, and no contraindications to aspirin or otherwise. Altogether, 14 892 patients were included (7351 to aspirin and 7541 to usual care group) in the final analysis. The primary outcome of all-cause mortality was unchanged with an equal proportion (17%) of patients dying in each group (1222 of 7351 with aspirin vs. 1299 of 7541 with usual care, rate ratio [RR] 0.96, 95% confidence interval [CI] 0.89-1.04, p=0.35). Likewise, there was marginal difference between groups regarding patients who required invasive mechanical ventilation (21% with aspirin vs. 22% with usual care, RR 0.96, 95% CI 0.90-1.03, p=0.23). However, aspirin was associated with decreased length of admission (8 days vs. 9 days) and increased likelihood of hospital discharge within 28 days (75% vs. 74%, p=0.0062) compared to usual care. Overall, aspirin did not show a significant difference in all-cause mortality among COVID-19 patients and its use in addition to routine thromboprophylaxis may be discouraged.

RELATED REPORTS

Awake prone positioning does not seem to offer benefit in reducing endotracheal intubation for COVID-19-induced acute respiratory failure: COVI-PRONE trial

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anticoagulationantiplateletaspirinCOVID-19SARS-CoV-2thromboembolismthrombosisvenous thromboembolism
Previous Post

Balanced-multi-electrolyte-solution does not reduce risk of death among intensive care patients

Next Post

Premorbid neurodegenerative disease associated with increased risk of COVID-19 infection and death

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Awake prone positioning does not seem to offer benefit in reducing endotracheal intubation for COVID-19-induced acute respiratory failure: COVI-PRONE trial

May 16, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

May 13, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

May 13, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

BNT162b2 safe and efficacious in children 5 to 11 years of age

May 13, 2022
Next Post

Premorbid neurodegenerative disease associated with increased risk of COVID-19 infection and death

#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

Novel coronavirus identified from patients with pneumonia in Wuhan, China

mRNA Covid-19 vaccine remained safe and efficacious through 6 months

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.